187 related articles for article (PubMed ID: 37327589)
21. Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers.
Mullarky E; Lucki NC; Beheshti Zavareh R; Anglin JL; Gomes AP; Nicolay BN; Wong JC; Christen S; Takahashi H; Singh PK; Blenis J; Warren JD; Fendt SM; Asara JM; DeNicola GM; Lyssiotis CA; Lairson LL; Cantley LC
Proc Natl Acad Sci U S A; 2016 Feb; 113(7):1778-83. PubMed ID: 26831078
[TBL] [Abstract][Full Text] [Related]
22. YY2 Promotes Osteoblast Differentiation by Upregulating Osterix Transcriptional Activity.
Piao M; Lee SH; Kim MJ; Kim HS; Lee KY
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457117
[TBL] [Abstract][Full Text] [Related]
23. eIF3i promotes colorectal cancer cell survival via augmenting PHGDH translation.
Zhang Y; Wan X; Yang X; Liu X; Huang Q; Zhou L; Zhang S; Liu S; Xiong Q; Wei M; Qiu L; Zhang B; Han J
J Biol Chem; 2023 Sep; 299(9):105177. PubMed ID: 37611825
[TBL] [Abstract][Full Text] [Related]
24. Biological roles of Yin Yang 2: Its implications in physiological and pathological events.
Li L; Li Y; Timothy Sembiring Meliala I; Kasim V; Wu S
J Cell Mol Med; 2020 Nov; 24(22):12886-12899. PubMed ID: 32969187
[TBL] [Abstract][Full Text] [Related]
25. Serine synthesis through PHGDH coordinates nucleotide levels by maintaining central carbon metabolism.
Reid MA; Allen AE; Liu S; Liberti MV; Liu P; Liu X; Dai Z; Gao X; Wang Q; Liu Y; Lai L; Locasale JW
Nat Commun; 2018 Dec; 9(1):5442. PubMed ID: 30575741
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of 3-phosphoglycerate dehydrogenase (PHGDH) by indole amides abrogates de novo serine synthesis in cancer cells.
Mullarky E; Xu J; Robin AD; Huggins DJ; Jennings A; Noguchi N; Olland A; Lakshminarasimhan D; Miller M; Tomita D; Michino M; Su T; Zhang G; Stamford AW; Meinke PT; Kargman S; Cantley LC
Bioorg Med Chem Lett; 2019 Sep; 29(17):2503-2510. PubMed ID: 31327531
[TBL] [Abstract][Full Text] [Related]
27. Serine Biosynthesis Is a Metabolic Vulnerability in IDH2-Driven Breast Cancer Progression.
Barnabas GD; Lee JS; Shami T; Harel M; Beck L; Selitrennik M; Jerby-Arnon L; Erez N; Ruppin E; Geiger T
Cancer Res; 2021 Mar; 81(6):1443-1456. PubMed ID: 33500247
[TBL] [Abstract][Full Text] [Related]
28. Serine synthesis pathway enzyme PHGDH is critical for muscle cell biomass, anabolic metabolism, and mTORC1 signaling.
Mäntyselkä S; Kolari K; Baumert P; Ylä-Outinen L; Kuikka L; Lahtonen S; Permi P; Wackerhage H; Kalenius E; Kivelä R; Hulmi JJ
Am J Physiol Endocrinol Metab; 2024 Jan; 326(1):E73-E91. PubMed ID: 37991454
[TBL] [Abstract][Full Text] [Related]
29. Limited Environmental Serine and Glycine Confer Brain Metastasis Sensitivity to PHGDH Inhibition.
Ngo B; Kim E; Osorio-Vasquez V; Doll S; Bustraan S; Liang RJ; Luengo A; Davidson SM; Ali A; Ferraro GB; Fischer GM; Eskandari R; Kang DS; Ni J; Plasger A; Rajasekhar VK; Kastenhuber ER; Bacha S; Sriram RK; Stein BD; Bakhoum SF; Snuderl M; Cotzia P; Healey JH; Mainolfi N; Suri V; Friedman A; Manfredi M; Sabatini DM; Jones DR; Yu M; Zhao JJ; Jain RK; Keshari KR; Davies MA; Vander Heiden MG; Hernando E; Mann M; Cantley LC; Pacold ME
Cancer Discov; 2020 Sep; 10(9):1352-1373. PubMed ID: 32571778
[TBL] [Abstract][Full Text] [Related]
30. Menin regulates the serine biosynthetic pathway in Ewing sarcoma.
Svoboda LK; Teh SSK; Sud S; Kerk S; Zebolsky A; Treichel S; Thomas D; Halbrook CJ; Lee HJ; Kremer D; Zhang L; Klossowski S; Bankhead AR; Magnuson B; Ljungman M; Cierpicki T; Grembecka J; Lyssiotis CA; Lawlor ER
J Pathol; 2018 Jul; 245(3):324-336. PubMed ID: 29672864
[TBL] [Abstract][Full Text] [Related]
31. The alternative activity of nuclear PHGDH contributes to tumour growth under nutrient stress.
Ma C; Zheng K; Jiang K; Zhao Q; Sha N; Wang W; Yan M; Chen T; Zhao Y; Jiang Y
Nat Metab; 2021 Oct; 3(10):1357-1371. PubMed ID: 34663976
[TBL] [Abstract][Full Text] [Related]
32. Expression of metastasis suppressor gene AES driven by a Yin Yang (YY) element in a CpG island promoter and transcription factor YY2.
Kakizaki F; Sonoshita M; Miyoshi H; Itatani Y; Ito S; Kawada K; Sakai Y; Taketo MM
Cancer Sci; 2016 Nov; 107(11):1622-1631. PubMed ID: 27561171
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of phosphoglycerate dehydrogenase inhibits proliferation and enhances cisplatin sensitivity in cervical adenocarcinoma cells by regulating Bcl-2 and caspase-3.
Jing Z; Heng W; Xia L; Ning W; Yafei Q; Yao Z; Shulan Z
Cancer Biol Ther; 2015; 16(4):541-8. PubMed ID: 25719555
[TBL] [Abstract][Full Text] [Related]
34. Targeting PHGDH reverses the immunosuppressive phenotype of tumor-associated macrophages through α-ketoglutarate and mTORC1 signaling.
Cai Z; Li W; Hager S; Wilson JL; Afjehi-Sadat L; Heiss EH; Weichhart T; Heffeter P; Weckwerth W
Cell Mol Immunol; 2024 May; 21(5):448-465. PubMed ID: 38409249
[TBL] [Abstract][Full Text] [Related]
35. PHGDH and cancer: new job for an old enzyme!
Kuzuoglu-Ozturk D
EMBO J; 2023 Feb; 42(3):e113068. PubMed ID: 36477891
[TBL] [Abstract][Full Text] [Related]
36. PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma.
Wang K; Luo L; Fu S; Wang M; Wang Z; Dong L; Wu X; Dai L; Peng Y; Shen G; Chen HN; Nice EC; Wei X; Huang C
Nat Commun; 2023 Feb; 14(1):1011. PubMed ID: 36823188
[TBL] [Abstract][Full Text] [Related]
37. Serine-dependent redox homeostasis regulates glioblastoma cell survival.
Engel AL; Lorenz NI; Klann K; Münch C; Depner C; Steinbach JP; Ronellenfitsch MW; Luger AL
Br J Cancer; 2020 Apr; 122(9):1391-1398. PubMed ID: 32203214
[TBL] [Abstract][Full Text] [Related]
38. Inhibiting phosphoglycerate dehydrogenase counteracts chemotherapeutic efficacy against MYCN-amplified neuroblastoma.
Arlt B; Zasada C; Baum K; Wuenschel J; Mastrobuoni G; Lodrini M; Astrahantseff K; Winkler A; Schulte JH; Finkler S; Forbes M; Hundsdoerfer P; Guergen D; Hoffmann J; Wolf J; Eggert A; Kempa S; Deubzer HE
Int J Cancer; 2021 Mar; 148(5):1219-1232. PubMed ID: 33284994
[TBL] [Abstract][Full Text] [Related]
39. Yin-Yang 1 and Yin-Yang 2 exert opposing effects on the promoter activity of interleukin 4.
Lee SH; Cho YC; Jeong HM; Kim KH; Choi HJ; Lee KY; Kang BY
Arch Pharm Res; 2016 Apr; 39(4):547-554. PubMed ID: 26345265
[TBL] [Abstract][Full Text] [Related]
40. The NAD
Murphy JP; Giacomantonio MA; Paulo JA; Everley RA; Kennedy BE; Pathak GP; Clements DR; Kim Y; Dai C; Sharif T; Gygi SP; Gujar S
Cell Rep; 2018 Aug; 24(9):2381-2391.e5. PubMed ID: 30157431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
